BMO Capital lowered the firm’s price target on Ingredion (INGR) to $133 from $147 and keeps a Market Perform rating on the shares after its Q4 results and outlook. The company’s EPS guidance mid-point was consistent with consensus, but the segment details were “disappointing” as operating income growth forecast is only up mid-single-digits, the analyst tells investors in a research note. BMO adds however that it is retainign a constructive view of steady-state fundamentals supported by ongoing volume recovery, accelerated cost savings, and growth projects.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio